SERVİKS KARSİNOMU VE YÜKSEK DERECELİ SKUAMOZİNTRAEPİTELYAL LEZYONLARDA SERUM FOLAT, VİTAMİN B12,HOMOSİSTEİN VE ESER ELEMENT DÜZEYLERİ
Amaç: Serviks kanseri ve yüksek dereceli skuamoz intraepitelyal lezyon(HSIL) tanısı alan hastalarda folat, vitamin B12 , homosistein, eser element çinko, bakır, demir), serum demir ba¤lama kapasitesi ve ferritin düzeylerinin karşılaştırılması. Materyal ve Metod: Hastanemiz jinekolojik onkoloji klini¤inde 2008-2011 yılları arasında takip ve tedavisi yapılan HSIL ve serviks karsinomu olguları retrospektif olarak incelendi. Elli dört olgu HSIL , 65 olgu ise serviks kanseri tanısı almıştı. Olguların yaşı, biyopsi tanı- sı, serum eser elementleri (çinko, bakır, demir), folat, vitamin B12, ferritin, homosistein düzeyleri ile serum demir ba¤lama kapasitesi (SDBK) kaydedilerek karşılaştırıldı. Olgular ayrıca yaşlarına göre gruplandırılarak karşılaştırıldı. Sonuçlar: Grupların çinko, demir, folat ve B12 ortalamaları arasında istatistiksel olarak anlamlı fark saptanmadı (p>0.05). Bakır, SDBK, ferritin ve homosistein düzeyleri arasında anlamlı fark saptandı (p<0.05). Yaş gruplarına göre, Grup 1(< 50) ile Grup 2 (50 yaş üstü) arasında, SDBK, ferritin, homosistein de¤erleri ortalamaları arasında anlamlı fark saptandı (p<0.001). Çinko, bakır, demir, folat, B12 de¤erleri ortalamaları arasında anlamlı fark yoktu (p>0.05). Sonuç: Serum eser elementleri, folat, vitamin B12 ve homosistein düzeylerinin preinvaziv lezyon oluşumu ve servikal karsinogenezdeki rolünün ortaya konulabilmesi için gelecek çalışmalara ihtiyaç vardır.
SERVİKS KARSİNOMU VE YÜKSEK DERECELİ SKUAMOZİNTRAEPİTELYAL LEZYONLARDA SERUM FOLAT, VİTAMİN B12,HOMOSİSTEİN VE ESER ELEMENT DÜZEYLERİ
Objective: To determine folate, vitamin B12, homocysteine, trace elements (zinc, copper, iron), serum iron binding capacity and ferritin levels in cervical cancer and high grade squamous intraepithelial lesion (HSIL) patients. Material and Methods: HSIL and cervical cancer patients, who treated in our gynecologic oncology unit between 2008-2011, were investigated retrospectively.Fifty-four patient were in HSIL group and 65 were in cervical cancer group. Folate, vitamin B12, homocysteine, trace elements (zinc, copper, iron), serum iron binding capacity and ferritin levels, patients age, diagnosis were recorded. Results: There was no statistical significant difference in zinc, iron, folate, B12 levels between HSIL and cervical cancer groups (p>0.05). Copper, serum iron binding capacity, ferritin, homocysteine levels were significantly different between two groups (p<0.05). Between different age groups (under 50 and above 50 years) there were significant difference in serum iron binding capacity, ferritin, homocysteine levels (p<0.001). However, no statistical significant difference in zinc, copper, folate, iron, B12 levels between two age groups were detected. (p>0.05). Conclusion: Future trials are needed to determine the role of serum trace elements, folate, vitamin B12 and homocystein levels in development of cervical preinvasive lesions and carcinogenesis.
___
- 1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman
D (2011) Global cancer statistics. CA Cancer J Clin 61
(2):69-90. doi:caac.20107 (pii) 10.3322/caac.20107.
- 2. Schiffman MH, Castle P (2003) Epidemiologic studies
of a necessary causal risk factor: human papillomavirus
infection and cervical neoplasia. J Natl Cancer Inst
95 (6):E2.
- 3. Ostor AG (1993) Natural history of cervical intraepithelial
neoplasia: a critical review. Int J Gynecol Pathol 12
(2):186-192.
- 4. Butterworth CE, Jr. (1992) Effect of folate on cervical
cancer. Synergism among risk factors. Ann N Y Acad
Sci 669:293-299.
- 5. Mason JB, Levesque T (1996) Folate: effects on carcinogenesis
and the potential for cancer chemoprevention.
Oncology (Williston Park) 10 (11):1727-1736, 1742-1723;
discussion 1743-1724.
- 6. Hoffbrand AV, Weir DG (2001) The history of folic
acid. Br J Haematol 113 (3):579-589. doi:bjh2822 (pii).
- 7. Alberg AJ, Selhub J, Shah KV, Viscidi RP, Comstock
GW, Helzlsouer KJ (2000) The risk of cervical cancer in
relation to serum concentrations of folate, vitamin B12,
and homocysteine. Cancer Epidemiol Biomarkers Prev
9 (7):761-764.
- 8. Flynn MA, Herbert V, Nolph GB, Krause G (1997) Atherogenesis
and the homocysteine-folate-cobalamin
triad: do we need standardized analyses? J Am Coll
Nutr 16 (3):258-267.
- 9. Weinstein SJ, Ziegler RG, Selhub J, Fears TR, Strickler
HD, Brinton LA, Hamman RF, Levine RS, Mallin K,
Stolley PD (2001) Elevated serum homocysteine levels
and increased risk of invasive cervical cancer in US women.
Cancer Causes Control 12 (4):317-324.
- 10. Martin-Lagos F, Navarro-Alarcon M, Terres-Martos C,
Lopez GdlSH, Lopez-Martinez MC (1997) Serum copper
and zinc concentrations in serum from patients
with cancer and cardiovascular disease. Sci Total Environ
204 (1):27-35. doi:S0048969797001630 (pii).
- 11. Lowndes SA, Adams A, Timms A, Fisher N, Smythe J,
Watt SM, Joel S, Donate F, Hayward C, Reich S, Middleton
M, Mazar A, Harris AL (2008) Phase I study of
copper-binding agent ATN-224 in patients with advanced
solid tumors. Clin Cancer Res 14 (22):7526-7534.
- doi:14/22/7526 (pii) 10.1158/1078-0432.CCR-08-0315
12. Wu T, Sempos CT, Freudenheim JL, Muti P, Smit E
(2004) Serum iron, copper and zinc concentrations and
risk of cancer mortality in US adults. Ann Epidemiol 14
(3):195-201. doi:10.1016/S1047-2797(03)00119-4
S1047279703001194 (pii).
- 13. Poljak-Blazi M, Jaganjac M, Sabol I, Mihaljevic B, Matovina
M, Grce M (2011) Effect of ferric ions on reactive
oxygen species formation, cervical cancer cell lines
growth and E6/E7 oncogene expression. Toxicol In Vitro
25 (1):160-166. doi:S0887-2333(10)00271-7 (pii)
10.1016/j.tiv.2010.10.013.
- 14. Lee DH, Zacharski LR, Jacobs DR, Jr. (2006) Comparison
of the serum ferritin and percentage of transferrin
saturation as exposure markers of iron-driven oxidative
stress-related disease outcomes. Am Heart J 151
(6):1247 e1241-1247. doi:S0002-8703(06)00266-3 (pii)
10.1016/j.ahj.2006.03.009.
- 15. Stevens RG, Cologne JB, Nakachi K, Grant EJ, Neriishi
K (2011) Body iron stores and breast cancer risk in female
atomic bomb survivors. Cancer Sci 102 (12):2236-
2240. doi:10.1111/j.1349-7006.2011.02080.x
- 16. Cross AJ, Sinha R, Wood RJ, Xue X, Huang WY, Yeager
M, Hayes RB, Gunter MJ (2011) Iron homeostasis and
distal colorectal adenoma risk in the prostate, lung, colorectal,
and ovarian cancer screening trial. Cancer
Prev Res (Phila) 4 (9):1465-1475. doi:1940-6207.CAPR11-0103
(pii) 10.1158/1940-6207.CAPR-11-0103